Industrial Enzyme Preparation - Acrylonitrile Hydratase Preparation
香港-海外项目平台 / 重点项目
香港-海外项目平台 / 重点项目
项目简介
Industrial Enzyme Project: Acrylonitrile Hydratase
Project Overview & Market Potential
This project focuses on the industrial enzyme preparation of acrylonitrile hydratase, aiming to achieve domestic substitution for Japanese enzymes. The latest enzyme technology product from Japan entered the Chinese market in 2021. Currently, it is a globally monopolized product with a domestic market size of RMB 1.5 billion and a compound annual growth rate (CAGR) of 30%.
Technological Advantages & Commercial Traction
Our product has successfully passed lab-scale and pilot-scale verification, matching the performance of Japanese enzymes, and has now reached the mass production stage. We are one of only two companies globally capable of producing this product, alongside the Japanese monopoly.
Cost Advantage: Our production cost is only 20%-30% of the Japanese equivalent, granting us independent pricing power and substantial profit margins.
Market Entry: With existing contract orders of RMB 58 million, our product can rapidly integrate into clients' supply chains.
Technical Barriers: Entering this industry requires extensive accumulation in genetic engineering and fermentation engineering. Notably, genetic engineering is recognized as one of the six frontier technologies.
Financial Projections (Phase I)
Financing Requirement: RMB 20 million
Projected Output Value: RMB 150 million
Projected Gross Profit: RMB 100 million
Founder's Profile: Mi Bo
Han Ethnicity | Born: February 1977
Education
Graduated from Shandong University, majoring in Chemical Engineering and Technology.
Professional Summary
With 25 years of dedicated experience in the production management and R&D of acrylamide, Mr. Mi has been granted 13 authorized invention patents in the acrylamide industry.
Professional Experience
Zhuhai Miaohan Biotechnology Co., Ltd. | Founder & General Manager | 2023 – Present
Founded the company and currently leads a highly qualified R&D and operations team of 11 professionals, including 5 Ph.D.s, 4 Master's degree holders, and 2 Bache